Flu Hospitalization Rate Week 16: Where Does the Market Land?

The CDC’s flu surveillance data is the only thing that settles this contract. Right now, traders are betting at 67.6% that the Week 16, 2026 flu hospitalization rate lands in the 85-to-90 range. That’s a majority lean, but it’s not a settled call. The market is pricing uncertainty, not science, and the spread across six outcome buckets tells you exactly how fragile that conviction is.

Total trading volume sits at $1,130 with $1,806 in liquidity. Those are thin numbers. In a market this illiquid, a single moderately sized trade can reprice the outcome by several percentage points. The 67.6% probability here reflects trader positioning, not a deep pool of informed capital. Treat the number accordingly.

How the Flu Hospitalization Rate Contract Works

This contract resolves based on the CDC’s reported flu hospitalization rate for Week 16 of the 2026 flu season. The CDC publishes this figure through its FluView surveillance system, which tracks laboratory-confirmed influenza hospitalizations per 100,000 population. Resolution follows whichever bucket captures the final reported rate.

• 85-90 (YES at $0.68, implied 67.6%): The weekly flu hospitalization rate falls between 85 and 90 per 100,000.
• 90-95: The rate falls between 90 and 95 per 100,000.
• Below 80: The rate drops below 80 per 100,000.
• 95-100: The rate falls between 95 and 100 per 100,000.
• 100+: The rate exceeds 100 per 100,000.
• 80-85: The rate falls between 80 and 85 per 100,000.

The NO side pays out if the CDC’s Week 16 figure lands anywhere outside the 85-to-90 bucket. That means five separate outcome buckets compete against the YES position. A rate that comes in at 84.9 or 90.1 both flip the contract to NO. With six possible resolution buckets in play, the trailing outcomes collectively represent real probability mass, even if no single bucket dominates.

Momentum and Market Signals

Sponsored Partner

The momentum composite here is essentially flat. The 1-hour change registers at zero, the 24-hour change is not available, and the trend score sits at 38.88. That combination points to a market in a holding pattern, waiting for the CDC’s next FluView release. Nothing is moving this contract in either direction right now. The data hasn’t arrived, and traders aren’t repositioning ahead of it.

Liquidity at $1,806 and volume at $1,130 confirm this is a low-activity market. Thin liquidity means price can move sharply on new data. When the CDC publishes Week 16 figures, expect the probability to reprice quickly and possibly dramatically. A small number of trades in an illiquid book will do the work that thousands of trades would do in a deeper market.

• 1-hour price change at +0.0%: No intraday movement, suggesting traders are waiting rather than reacting.
• 24-hour change unavailable: Absence of recent directional data reduces signal confidence for short-term positioning.
• Trend score of 38.88: Below midpoint, consistent with a market that hasn’t established clear directional momentum.
• Volume of $1,130: Extremely thin for a science-data contract. Single trades can move the market meaningfully.
• Six competing outcome buckets: Probability is fragmented. The YES bucket holds plurality, not majority certainty.

Lines Analysis: What the CDC Data Will Decide

The 85-to-90 bucket commands plurality support for a reason. Late flu season hospitalization rates in the United States have historically clustered in a range consistent with a winding-down epidemic wave. If Week 16 represents a declining but still elevated flu burden, the 85-to-90 range is plausible. The CDC’s FluView trajectory through recent weeks would need to show a moderate plateau or gradual decline landing in that window. The market is pricing that scenario as the most likely single outcome, even though the combined probability of all other buckets exceeds 32%.

The conditions that shift this contract away from 85-to-90 are specific. A faster-than-expected decline in flu activity pushes the rate below 85, potentially into the 80-to-85 or sub-80 bucket. A slower decline, or a secondary wave driven by a circulating strain not well-matched to this season’s vaccine, pushes the rate above 90. The CDC’s hospitalization data is not revised heavily after initial release, so the first published Week 16 figure is almost certainly the resolution figure. Traders betting against the 85-to-90 bucket need one of those directional misses to materialize.

Signals to monitor before 2026-05-01 resolution:

• The CDC FluView Week 16 publication, expected in late April or early May 2026, is the single data point that resolves this contract outright.
• Week 15 hospitalization rate trends will provide the clearest leading indicator for where Week 16 lands. A sharp Week 15 decline points toward sub-85; a plateau points toward 85-to-90 or above.
• CDC’s ILINet outpatient data for weeks 14 and 15 signals upstream activity that leads hospitalization figures by roughly one to two weeks.
• Geographic concentration of flu activity matters. A regionally concentrated late surge can push national rates above 90 even as most of the country quiets down.
• Any CDC advisory or health alert issued between now and resolution would signal an anomalous pattern and likely push prices away from the 85-to-90 bucket.

The $1,130 in volume confirms this is a lightly traded contract. The data favors the 85-to-90 bucket as the plurality outcome, but thin liquidity and six competing resolution ranges mean the market’s 67.6% confidence could reprice sharply in either direction the moment CDC publishes Week 16 figures. The CDC’s FluView release is the only thing that matters from here.

LINES VERDICT

Plurality Lean, Fragile Conviction

The 85-to-90 bucket holds the strongest single-outcome position, but six competing resolution ranges and a thin liquidity pool mean this market can move dramatically on a single CDC data release.

What the market says: Traders assign 67.6% probability to a Week 16 flu hospitalization rate between 85 and 90. That’s a plurality lean in a fragmented field. With resolution on 2026-05-01, the CDC FluView publication will settle this contract within days, and prices could reprice sharply given the thin order book.

Key unknown: The CDC’s Week 16 FluView hospitalization figure is the only data point that resolves this contract. Until that number publishes, the 67.6% probability reflects trader positioning against a backdrop of genuine scientific uncertainty about where a late-season flu wave plateaus.

Scientific and Surveillance Context

CDC FluView tracks influenza-associated hospitalizations through a network of approximately 250 acute care hospitals across 14 states. The weekly hospitalization rate is expressed as laboratory-confirmed flu hospitalizations per 100,000 population. Week 16 of the 2026 flu season corresponds to mid-to-late April, a period when flu activity in the United States has historically transitioned from peak season decline toward inter-seasonal lows. The 85-to-90 range represents an elevated but declining rate consistent with a season winding down rather than resurging. Historical seasons with late-running H3N2 or influenza B activity have occasionally sustained elevated hospitalization rates into April, which is the primary scientific basis for the non-trivial probability assigned to buckets above 90. Any unexpected variant circulation or vaccine mismatch with late-season strains would be the scientific mechanism pushing the rate above the 85-to-90 ceiling before 2026-05-01 resolution.

Frequently Asked Questions

• What does 67.6% probability mean here? It means traders currently assign a 67.6% chance that the CDC’s Week 16 flu hospitalization rate lands between 85 and 90 per 100,000. It reflects collective market positioning, not a scientific forecast.
• What makes the NO outcome pay out? Any CDC Week 16 figure outside the 85-to-90 range resolves the contract against YES. That includes five other buckets: below 80, 80-to-85, 90-to-95, 95-to-100, and 100 or above.
• What single event would move this market most? The CDC FluView Week 16 publication. That data release is the resolution trigger and will reprice the contract immediately upon release.
• When does this market resolve? The resolution deadline is 2026-05-01 at 00:00:00. The CDC typically publishes Week 16 FluView data in the final days of April or first days of May.
• Is the $1,130 volume enough to trust this price? No. Volume of $1,130 and liquidity of $1,806 indicate a very thin market. A small number of trades can move the probability significantly. The 67.6% figure should be read as a directional signal, not a precise estimate.

This analysis reflects market conditions as of 2026-04-25. Prediction market probabilities are volatile and shift as new data and regulatory decisions emerge, especially as the 2026-05-01 00:00:00 resolution date approaches. Lines.com does not accept bets or provide financial or gambling advice. All market outcomes are uncertain.